Armen B. Shanafelt Ph.D.
General Partner ,Lilly Ventures
|Age||Total Calculated Compensation||This person is connected to 70 board members in 9 different organizations across 10 different industries.|
See Board Relationships
Dr. Armen B. Shanafelt, Ph.D., is a General Partner and Venture Partner at Lilly Ventures. Prior to joining Lilly Ventures, Dr. Shanafelt served as the Chief Scientific Officer at Eli Lilly and Company and was responsible for the generation of the early biotherapeutic pipeline, spanning the therapeutic areas of oncology, endocrine and neuroscience. He was a Venture Partner at Lilly Ventures. During Dr. Shanafelt’s seven years with Lilly, the biotherapeutic group delivered ...
115 West Washington StreetPhone: 317-429-0140
Indianapolis, Indiana 46204
Board Members Memberships*
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
University of California Berkeley
Pacific Lutheran University Inc
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.